Dahl K, Baekdal TA. Response to the letter from Horowitz et al to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et al. Diabetes Obes Metab 2021 Jul 1. doi: 10.1111/dom.14485.
PMID: 34212484